IBO
AMEX · Pharmaceuticals
Impact Biomedical Inc
$0.44
-0.01 (-2.17%)
Open$0.46
Previous Close$0.45
Day High$0.46
Day Low$0.43
52W High$0.83
52W Low$0.37
Volume—
Avg Volume29.9K
Market Cap48.61M
P/E Ratio—
EPS$-1.26
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 110.2K | 2.01M | 2.09M |
| Net Income | -41,353,516 | 252.5K | 255.6K |
| Profit Margin | -36,993.8% | 12.5% | 12.2% |
| EBITDA | -10,955,595 | 413.4K | 402.4K |
| Free Cash Flow | — | 302.8K | 206.2K |
| Rev Growth | — | +12.9% | +6.5% |
| Debt/Equity | 0.05 | 0.52 | 0.58 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |